Skip to main content

Day: October 9, 2024

Lipella Pharmaceuticals to Present at 2024 Maxim Healthcare Virtual Summit

PITTSBURGH, Oct. 09, 2024 (GLOBE NEWSWIRE) — Lipella Pharmaceuticals, Inc. (Nasdaq: LIPO) (“Lipella” or the “Company”), a clinical-stage biotechnology company focused on addressing serious diseases with significant unmet needs, today announced that CEO Jonathan Kaufman, PhD will be presenting at the 2024 Maxim Healthcare Virtual Summit that is being held on October 15 -17, 2024. Event: Lipella Presentation – 2024 Maxim Healthcare Virtual Summit Date: Thursday, October 17th, 2024 Time: 10:30am Webcast: https://m-vest.com/events/healthcare-10152024 Jonathan Kaufman will be available for one-on-one meetings with registered investors of the conference. About Lipella PharmaceuticalsLipella is a clinical-stage biotechnology company focused on developing new drugs by reformulating the active agents in existing generic drugs and...

Continue reading

Commercial insurance market projects stability as rates moderate across most lines of business

NEW YORK, Oct. 09, 2024 (GLOBE NEWSWIRE) — According to the latest Insurance Marketplace Realities report from WTW (Willis Towers Watson, NASDAQ: WTW), a leading global advisory, broking and solutions company, commercial insurance rates have demonstrated balance and stability throughout the year across North America. Jon Drummond, Head of Broking, North America, WTW, commented, “The industry has not categorically rewritten its position on any one line of business, but rather has taken micro-actions reacting to emerging trends.” WTW reports that new capital in both the reinsurance and retail marketplace has led to increased competition for premium market share, excluding umbrella and excess liability. This trend has played out across the industry, which is particularly meaningful in 1st party business where capacity was a challenge...

Continue reading

Northrop Grumman Unveils the Next Generation of Bushmaster® Chain Gun®

For the first time operators can change between advanced ammunition rounds with the flip of a switch PLYMOUTH, Minn., Oct. 09, 2024 (GLOBE NEWSWIRE) — Northrop Grumman Corporation (NYSE: NOC), a leading manufacturer of medium-caliber cannons, is introducing its next-generation M230 Link Fed (M230LF) Dual Feed Bushmaster® Chain Gun®, offering two ammunition feed paths for the first time. This new 30x113mm medium caliber chain gun is a proven variant of the M230LF chain gun to counter uncrewed aerial threats (C-UAS) and ground engagements.By offering a dual feed, the need for mixed ammunition belts in a single feed is eliminated. The ability to switch between two kinds of ammunition is now possible. A standard recommended ammunition load includes XM1211 proximity fuzed rounds for C-UAS and XM1198 high explosive, dual purpose rounds...

Continue reading

PTX Metals Appoints Dave Bell as a Technical Advisor to Its 100% Owned W2 Copper, Nickel, PGE and Gold Project

TORONTO, Oct. 09, 2024 (GLOBE NEWSWIRE) — PTX Metals Inc. (CSE: PTX) (OTCQB: PANXF, Frankfurt: 9PX) (“PTX” or the “Company”), a mineral exploration Company focused on high-quality gold, copper, nickel and PGE projects in northern Ontario, is pleased to announce the appointment of Dave Bell to its technical team to further assist PTX with the development and advancement of its W2 Cu, Ni, PGE and Au project in northwestern Ontario. With 25 years of experience in community engagement, government relations, and environmental permitting Dave brings significant knowledge and experience to the team. This includes as former Director of Environment at Wyloo Metals (Canada) and project management at the Impact Assessment Agency of Canada and the Ontario Ministry of Environment Conservation and Parks. Dave has worked on permitting and engagement...

Continue reading

Portfolio Update: New Stock Picker Appointed for Alliance Witan

Alliance Witan PLC (the “Company”)LEI: 213800SZZD4E21OZ9W55 Portfolio Update: New Stock Picker Appointed for Alliance Witan Alliance Witan PLC (“Alliance Witan” or the “Company”) announces that its investment manager, Willis Towers Watson (“WTW”), has appointed Jennison Associates (“Jennison”) as an additional stock picker for its multi-manager global equity portfolio, taking the total number of stock pickers to eleven. New York and Boston-based Jennison was founded in 1969. It has $210 billion of assets under management (as of 30 June 2024) and specialises in investing in companies with exceptional growth prospects. Jennison previously managed part of the multi-manager global equity portfolio of Witan Investment Trust (“Witan”) before the latter’s combination with Alliance Trust plc to create Alliance Witan (the “Combination”), which...

Continue reading

SEALSQ Getting Ready for the Arrival of Quantum Computers as Post-Quantum Cryptographic Algorithms and Semiconductors are the Front-Line of defense Against Adversarial Quantum Attacks

Geneva, Switzerland, Oct. 09, 2024 (GLOBE NEWSWIRE) — SEALSQ Corp (NASDAQ: LAES) (“SEALSQ” or “Company”), a company that focuses on developing and selling Semiconductors, PKI and Post-Quantum technology hardware and software products, today announced that it is positioning itself at the forefront of defense against adversarial quantum attacks with cutting-edge post-quantum cryptographic algorithms. As quantum-computing brings a paradigm shift in computational power by harnessing the principles of quantum mechanics, the need for enhanced security has never been greater. To address these emerging challenges, the SEALSQ team — led by Nascimo Madieta, Guillaume Aymard, and Daniele Fronte — recently published their research titled “Memory Efficient Implementations of CRYSTALS-Kyber,” developed in collaboration...

Continue reading

Blood Screening Market Growth at USD 6.33 Billion by 2031 | SkyQuest Technology

Discover the booming blood screening market from 2024 to 2031, as innovative technologies and rising health awareness drive demand across diverse product types and end users. This insightful analysis reveals key growth trends and regional dynamics shaping the future of diagnostics. Westford, USA, Oct. 09, 2024 (GLOBE NEWSWIRE) — Global Blood Screening Market size was valued at USD 3.30 Billion in 2023 to USD 6.33 Billion by 2031, at a CAGR of 8.50% during the forecast period (2024-2031). Blood screening is the process of screening donated blood. It is used to screen donated blood for HBV, HCV, HIV1, and HIV2. High market growth is driven by increased blood donations and increased incidence of infectious diseases, as well as government support. The World Health Organization reports that 118.54 million blood donations are collected...

Continue reading

MJH Life Sciences® acquires EnVision Summit, expands leadership in eye care education

The longstanding CME-certified conference increases MJH Life Sciences’ framework for novel educational experiences and expanded medical communications for ophthalmologists. CRANBURY, N.J., Oct. 09, 2024 (GLOBE NEWSWIRE) — MJH Life Sciences®, a leading provider of health care events, media and education, announced today its acquisition of the EnVision Summit, a premier certified continuing medical education (CME) conference for ophthalmologists, held annually in Puerto Rico. This acquisition supports one of MJH Life Sciences’ core pillars: Providing impactful educational experiences aimed at improving the care of patients. The EnVision Summit, known for blending innovative CME-certified education in ophthalmology with a first-class family experience, will be integrated into the MJH Life Sciences multichannel model. The summit will...

Continue reading

FE International Advises the Acquisition of DropFunnels by OptionScout

NEW YORK, Oct. 09, 2024 (GLOBE NEWSWIRE) — FE International, the award-winning strategic advisor for technology businesses, is pleased to announce the successful acquisition of DropFunnels, an all-in-one marketing solution, by OptionScout, a FinTech platform. From landing page creation to SEO optimization to sales tracking, DropFunnels was designed to help founders launch products faster. It’s easy-to-use and customizable, making it flexible to specific business needs—a feature Jordan Mederich, Founder, found lacking in other solutions. “It’s hard as a solo entrepreneur to launch your business very quickly and rapidly iterate to get you the results that you need,” said Mederich. “I decided that there had to be a better way. I wanted to build a sales and marketing tool that would allow anyone, from any background, to very...

Continue reading

StepStone Private Wealth Surpasses $5 Billion in AUM Milestone

NEW YORK, Oct. 09, 2024 (GLOBE NEWSWIRE) — StepStone Private Wealth (“SPW”) today announced it has surpassed $5 billion in global assets under management, making it one of the fastest growing private market asset managers serving financial professionals and their high net worth clients. Powered by StepStone Group, one of the largest global institutional allocators to the private markets, SPW was founded in 2019 to expand access to these assets for the private wealth market. “In 2019, the mission of our founding team was to design a platform where financial professionals could more easily access private markets, reducing the friction and burden of investing in these opportunities,” said Bob Long, CEO of StepStone Private Wealth. “Reaching $5 billion in AUM in five years demonstrates that advisors are eager to allocate client assets...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.